Impact of perinatal environmental health education intervention on exposure to endocrine disruptors during pregnancy-PREVED study: study protocol for a randomized controlled trial.

Endocrine disruptors Environmental health Intervention research Maternal exposure Pregnancy Randomized controlled trial

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
04 Dec 2021
Historique:
received: 22 09 2020
accepted: 10 11 2021
entrez: 5 12 2021
pubmed: 6 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

The suspected or actual effects on health of endocrine-disrupting chemicals (EDC) and their ubiquitous presence in everyday life justify the implementation of health promotion interventions. These interventions should ideally be applied during critical windows like pregnancy. Perinatal environmental health education interventions may help to reduce EDC exposure during pregnancy. PREVED (Pregnancy, PreVention, Endocrine Disruptors) is an open-label randomized controlled trial assessing the impact of environmental health education intervention on EDC exposure during pregnancy. Inclusion, consent, and randomization take place during the first trimester. The participants are randomly allocated into three groups: (i) control group (information leaflet on EDCs), (ii) intervention group in neutral location (information leaflet and workshops in a meeting room), and (iii) intervention group in contextualized location (information leaflet and workshops in a real apartment). Workshops are organized between the second and third trimesters of pregnancy. Main outcome is the percentage of participants who reported consuming manufactured/industrial food. Secondary outcomes are as follows: (i) psycho-social dimensions, (ii) EDC concentrations in urine, (iii) EDC concentration in colostrum, and (iv) percentage of participants who reported consuming paraben-free personal care products. PREVED is a ground-breaking intervention research project dedicated to perinatal environmental health education that aims to identify pollutant sources in daily life and to offer accessible and realistic alternative solutions, by promoting the sharing of know-how and experience in a positive and non-alarmist approach. ClinicalTrials.gov : NCT03233984 (current status: ongoing). Retrospectively registered on 31 July 2017 ( https://clinicaltrials.gov/ct2/show/NCT03233984 ) because when the first participant was enrolled in this non-drug intervention, ClinicalTrials.gov was centered in therapeutic trials. The World Health Organization Trial Registration Data Set is in Additional file 1.

Sections du résumé

BACKGROUND BACKGROUND
The suspected or actual effects on health of endocrine-disrupting chemicals (EDC) and their ubiquitous presence in everyday life justify the implementation of health promotion interventions. These interventions should ideally be applied during critical windows like pregnancy. Perinatal environmental health education interventions may help to reduce EDC exposure during pregnancy.
METHODS/DESIGN METHODS
PREVED (Pregnancy, PreVention, Endocrine Disruptors) is an open-label randomized controlled trial assessing the impact of environmental health education intervention on EDC exposure during pregnancy. Inclusion, consent, and randomization take place during the first trimester. The participants are randomly allocated into three groups: (i) control group (information leaflet on EDCs), (ii) intervention group in neutral location (information leaflet and workshops in a meeting room), and (iii) intervention group in contextualized location (information leaflet and workshops in a real apartment). Workshops are organized between the second and third trimesters of pregnancy. Main outcome is the percentage of participants who reported consuming manufactured/industrial food. Secondary outcomes are as follows: (i) psycho-social dimensions, (ii) EDC concentrations in urine, (iii) EDC concentration in colostrum, and (iv) percentage of participants who reported consuming paraben-free personal care products.
DISCUSSION CONCLUSIONS
PREVED is a ground-breaking intervention research project dedicated to perinatal environmental health education that aims to identify pollutant sources in daily life and to offer accessible and realistic alternative solutions, by promoting the sharing of know-how and experience in a positive and non-alarmist approach.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov : NCT03233984 (current status: ongoing). Retrospectively registered on 31 July 2017 ( https://clinicaltrials.gov/ct2/show/NCT03233984 ) because when the first participant was enrolled in this non-drug intervention, ClinicalTrials.gov was centered in therapeutic trials. The World Health Organization Trial Registration Data Set is in Additional file 1.

Identifiants

pubmed: 34863252
doi: 10.1186/s13063-021-05813-5
pii: 10.1186/s13063-021-05813-5
pmc: PMC8642981
doi:

Substances chimiques

Endocrine Disruptors 0

Banques de données

ClinicalTrials.gov
['NCT03233984']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

876

Subventions

Organisme : Fondation de France (FR)
ID : 784314908

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s).

Références

Chianese R, Troisi J, Richards S, Scafuro M, Fasano S, Guida M, et al. Bisphenol A in reproduction: epigenetic effects. Curr Med Chem. 2018 Feb 21;25(6):748–70. https://doi.org/10.2174/0929867324666171009121001 .
doi: 10.2174/0929867324666171009121001 pubmed: 28990514 pmcid: 28990514
Darbre PD. Endocrine disruptors and obesity. Curr Obes Rep. 2017 Mar;6(1):18–27. https://doi.org/10.1007/s13679-017-0240-4 .
doi: 10.1007/s13679-017-0240-4 pubmed: 28205155 pmcid: 28205155
Rivollier F, Krebs MO, Kebir O. Perinatal exposure to environmental endocrine disruptors in the emergence of neurodevelopmental psychiatric diseases: a systematic review. Int J Environ Res Public Health. 2019 Apr;12(8):16(8). https://doi.org/10.3390/ijerph16081318 .
doi: 10.3390/ijerph16081318
Von Ehrenstein OS, Ling C, Cui X, Cockburn M, Park AS, Yu F, Wu J, Ritz B. Prenatal and infant exposure to ambient pesticides and autism spectrum disorder in children: population based case-control study. BMJ. 2019 Mar 20;364:l962. doi: https://doi.org/10.1136/bmj.l962 . Erratum in: BMJ. 2019 Jun 25;365:l4032.
Skogen JC, Overland S. The fetal origins of adult disease: a narrative review of the epidemiological literature. JRSM Short Rep. 2012 Aug;3(8):59. https://doi.org/10.1258/shorts.2012.012048 .
doi: 10.1258/shorts.2012.012048 pubmed: 23301147 pmcid: 23301147
Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009 Sep;27(5):358–68. https://doi.org/10.1055/s-0029-1237424 .
doi: 10.1055/s-0029-1237424 pubmed: 19711246 pmcid: 19711246
Newnham JP. The developmental origins of health and disease (DOHaD) - why it is so important to those who work in fetal medicine. Ultrasound Obstet Gynecol. 2007 Feb;29(2):121–3. https://doi.org/10.1002/uog.3938 .
doi: 10.1002/uog.3938 pubmed: 17252533 pmcid: 17252533
Soubry A. POHaD: why we should study future fathers. Environ Epigenet. 2018 Apr 26;4(2):dvy007.
doi: 10.1093/eep/dvy007
Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1847–50. https://doi.org/10.1158/1055-9965.EPI-05-0456 .
doi: 10.1158/1055-9965.EPI-05-0456 pubmed: 16103423 pmcid: 16103423
Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012 Feb;41(1):24–32. https://doi.org/10.1093/ije/dyr236 .
doi: 10.1093/ije/dyr236 pubmed: 22296988 pmcid: 22296988
Varshavsky J, Smith A, Wang A, Hom E, Izano M, Huang H, et al. Heightened susceptibility: a review of how pregnancy and chemical exposures influence maternal health. Reprod Toxicol. 2020 Mar;92:14–56. https://doi.org/10.1016/j.reprotox.2019.04.004 Epub 2019 May 2.
World Health Organisation. Chapter 1: Executive Summary. In: Global assessment of the state-of-the-science of endocrine disruptors. http://www.who.int/ipcs/publications/new_issues/endocrine_disruptors/en/ (2015) Accessed 6 May 2021.
Kabir ER, Rahman MS, Rahman I. A review on endocrine disruptors and their possible impacts on human health. Environ Toxicol Pharmacol. 2015 Jul;40(1):241–58. https://doi.org/10.1016/j.etap.2015.06.009 .
doi: 10.1016/j.etap.2015.06.009 pubmed: 26164742 pmcid: 26164742
Fenichel P, Brucker-Davis F, Chevalier N. Perturbateurs endocriniens – Reproduction et cancers hormono-dépendants [Endocrine disruptors, reproduction and hormone-dependent cancers]. Presse Med. 2016 Jan;45(1):63–72. https://doi.org/10.1016/j.lpm.2015.10.017 .
doi: 10.1016/j.lpm.2015.10.017 pubmed: 26655259 pmcid: 26655259
Lauretta R, Sansone A, Sansone M, Romanelli F, Appetecchia M. Endocrine disrupting chemicals: effects on endocrine glands. Front Endocrinol (Lausanne). 2019 Mar 21;10:178.
doi: 10.3389/fendo.2019.00178
Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017 Mar;68:3–33. https://doi.org/10.1016/j.reprotox.2016.10.001 .
doi: 10.1016/j.reprotox.2016.10.001 pubmed: 27760374 pmcid: 27760374
Tournaire M, Epelboin S, Devouche E. Diethylstilbestrol story. Therapie. 2014 Jan-Feb;69(1):101–14. https://doi.org/10.2515/therapie/2014012 .
doi: 10.2515/therapie/2014012 pubmed: 24698194 pmcid: 24698194
Fénichel P, Brucker-Davis F, Chevalier N. The history of Distilbène® (Diethylstilbestrol) told to grandchildren-the transgenerational effect. Ann Endocrinol (Paris). 2015 Jul;76(3):253–9. https://doi.org/10.1016/j.ando.2015.03.008 .
doi: 10.1016/j.ando.2015.03.008 pubmed: 25934356 pmcid: 25934356
Hatch EE, Troisi R, Palmer JR, Wise LA, Titus L, Strohsnitter WC, et al. Prenatal diethylstilbestrol exposure and risk of obesity in adult women. J Dev Orig Health Dis. 2015 Jun;6(3):201–7. https://doi.org/10.1017/S2040174415000033 .
doi: 10.1017/S2040174415000033 pubmed: 25697972 pmcid: 25697972
Anonymous [No authors listed]. Diethylstilbestrol (DES): also harms the third generation. Prescrire Int. 2016 Dec;25(177):294-298. PMID: 30758926 .
Mallozzi M, Bordi G, Garo C, Caserta D. The effect of maternal exposure to endocrine disrupting chemicals on fetal and neonatal development: a review on the major concerns. Birth Defects Res C Embryo Today. 2016 Sep;108(3):224–42. https://doi.org/10.1002/bdrc.21137 .
doi: 10.1002/bdrc.21137 pubmed: 27653964 pmcid: 27653964
Wright RO. Environment, susceptibility windows, development, and child health. Curr Opin Pediatr. 2017 Apr;29(2):211–7. https://doi.org/10.1097/MOP.0000000000000465 .
doi: 10.1097/MOP.0000000000000465 pubmed: 28107208 pmcid: 28107208
European Commission: Conclusions and recommendations. https://ec.europa.eu/environment/chemicals/endocrine/documents/reports_conclusions_en.htm (2016).
European Commission: Communication from the commission to the european parliament, the council, the european economic and social committee and the committee of the regions. http://ec.europa.eu/transparency/regdoc/rep/1/2018/EN/COM-2018-734-F1-EN-MAIN-PART-1.PDF (2018).
Gee D. Late lessons from early warnings: toward realism and precaution with endocrine-disrupting substances. Environ Health Perspect. 2006 Apr;114(Suppl 1):152–60. https://doi.org/10.1289/ehp.8134 .
doi: 10.1289/ehp.8134 pubmed: 16818262 pmcid: 16818262
Stephenson J, Fleming TP, Godfrey KM, Barker M. Preconception health - authors’ reply. Lancet. 2018 Nov 24;392(10161):2267. https://doi.org/10.1016/S0140-6736(18)32169-X .
doi: 10.1016/S0140-6736(18)32169-X pubmed: 30496120 pmcid: 30496120
Heindel JJ, Vandenberg LN. Developmental origins of health and disease: a paradigm for understanding disease cause and prevention. Curr Opin Pediatr. 2015 Apr;27(2):248–53. https://doi.org/10.1097/MOP.0000000000000191 .
doi: 10.1097/MOP.0000000000000191 pubmed: 25635586 pmcid: 25635586
Grason HA, Misra DP. Reducing exposure to environmental toxicants before birth: moving from risk perception to risk reduction. Public Health Rep. 2009 Sep-Oct;124(5):629–41. https://doi.org/10.1177/003335490912400505 .
doi: 10.1177/003335490912400505 pubmed: 19753941 pmcid: 19753941
Fitzsimons D, Dwyer JT, Palmer C, Boyd LD. Nutrition and oral health guidelines for pregnant women, infants, and children. J Am Diet Assoc. 1998 Feb;98(2):182–6, 189 . https://doi.org/10.1016/S0002-8223(98)00044-3 .quiz 187-8.
Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, et al. Black RE; Lancet Nutrition Interventions Review Group, the Maternal and Child Nutrition Study Group. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013 Aug 3;382(9890):452–77. https://doi.org/10.1016/S0140-6736(13)60996-4 .
doi: 10.1016/S0140-6736(13)60996-4 pubmed: 23746776 pmcid: 23746776
Koletzko B, Godfrey KM, Poston L, Szajewska H, van Goudoever JB, de Waard M, et al. Zalewski BM; EarlyNutrition Project Systematic Review Group. Nutrition during pregnancy, lactation and early childhood and its implications for maternal and long-term child health: the Early Nutrition Project recommendations. Ann Nutr Metab. 2019;74(2):93–106. https://doi.org/10.1159/000496471 .
doi: 10.1159/000496471 pubmed: 30673669 pmcid: 30673669
Siu AL. U.S. Preventive Services Task Force. Screening for iron deficiency anemia and iron supplementation in pregnant women to improve maternal health and birth outcomes: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015 Oct 6;163(7):529–36. https://doi.org/10.7326/M15-1707 .
doi: 10.7326/M15-1707 pubmed: 26344176 pmcid: 26344176
Oliveira C, Imakawa TDS, Moisés ECD. Physical activity during pregnancy: recommendations and assessment tools. Rev Bras Ginecol Obstet. 2017 Aug;39(8):424-432. English. doi: https://doi.org/10.1055/s-0037-1604180 . Epub 2017 Aug 7. Erratum in: Rev Bras Ginecol Obstet. 2017 Oct;39(10):584.
Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Ishaku S; International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018 Jul;72(1):24–43. https://doi.org/10.1161/HYPERTENSIONAHA.117.10803 .
doi: 10.1161/HYPERTENSIONAHA.117.10803 pubmed: 29899139 pmcid: 29899139
Sahebi Z, Kazemi A, Loripour M, Shams N. An educational intervention to men for reducing environmental tobacco smoke exposure in their pregnant wives. J Matern Fetal Neonatal Med. 2019 May;32(10):1595–601. https://doi.org/10.1080/14767058.2017.1410792 .
doi: 10.1080/14767058.2017.1410792 pubmed: 29179601 pmcid: 29179601
Risica PM, Gavarkovs A, Parker DR, Jennings E, Phipps M. A tailored video intervention to reduce smoking and environmental tobacco exposure during and after pregnancy: rationale, design and methods of Baby's Breath. Contemp Clin Trials. 2017 Jan;52:1–9. https://doi.org/10.1016/j.cct.2016.10.010 .
doi: 10.1016/j.cct.2016.10.010 pubmed: 27818283 pmcid: 27818283
Zlatnik MG. Endocrine-disrupting chemicals and reproductive health. J Midwifery Women Health. 2016 Jul;61(4):442–55. https://doi.org/10.1111/jmwh.12500 .
doi: 10.1111/jmwh.12500
Barrett ES, Velez M, Qiu X, Chen SR. Reducing prenatal phthalate exposure through maternal dietary changes: results from a pilot study. Matern Child Health J. 2015 Sep;19(9):1936–42. https://doi.org/10.1007/s10995-015-1707-0 .
doi: 10.1007/s10995-015-1707-0 pubmed: 25652062 pmcid: 25652062
Agence Régionale de Santé Nouvelle-Aquitaine: Regional Strategy for Environmental Health around Early Childhood [Stratégie régionale en santé environnementale autour de la petite enfance]. https://www.nouvelle-aquitaine.ars.sante.fr/strategie-regionale-en-sante-environnementale-autour-de-la-petite-enfance (2019). Accessed 6 May 2020.
Bourguignon JP, Parent AS, Kleinjans JCS, Nawrot TS, Schoeters G, Van Larebeke N. Rationale for Environmental Hygiene towards global protection of fetuses and young children from adverse lifestyle factors. Environ Health. 2018 Apr 23;17(1):42. https://doi.org/10.1186/s12940-018-0385-y .
doi: 10.1186/s12940-018-0385-y pubmed: 29685149 pmcid: 29685149
Polinski KJ, Dabelea D, Hamman RF, Adgate JL, Calafat AM, Ye X, et al. Distribution and predictors of urinary concentrations of phthalate metabolites and phenols among pregnant women in the Healthy Start Study. Environ Res. 2018 Apr;162:308–17. https://doi.org/10.1016/j.envres.2018.01.025 .
doi: 10.1016/j.envres.2018.01.025 pubmed: 29407762 pmcid: 29407762
IREPS (Instance Régionale d'Education et de Promotion de la Santé) Nouvelle-Aquitaine : Workshop 19, a pedagogical housing on environment-health. [L’atelier du 19, un logement pédagogique environnement-santé]. https://irepsna.org/actions/latelier-du-19/ (2015).
Rouillon S, Deshayes-Morgand C, Enjalbert L, Rabouan S, Hardouin JB. Group DisProSE, Migeot V, Albouy-Llaty M. Endocrine disruptors and pregnancy: knowledge, attitudes and prevention behaviors of French women. Int J Environ Res Public Health. 2017 Sep;6(9):14(9). https://doi.org/10.3390/ijerph14091021 .
doi: 10.3390/ijerph14091021
Rouillon S, El Ouazzani H, Rabouan S, Migeot V, Albouy-Llaty M. Determinants of risk perception related to exposure to endocrine disruptors during pregnancy: a qualitative and quantitative study on French women. Int J Environ Res Public Health. 2018 Oct 11;15(10). pii: E2231. doi: 10.3390/ijerph15102231.
Albouy-Llaty M, Rouillon S, El Ouazzani H, DisProSE G, Rabouan S, Migeot V. Environmental health knowledge, attitudes, and practices of French prenatal professionals working with a socially underprivileged population: a qualitative study. Int J Environ Res Public Health. 2019 Jul 16;16(14). pii: E2544. doi: 10.3390/ijerph16142544.
Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013 Aug;46(1):81–95. https://doi.org/10.1007/s12160-013-9486-6 .
doi: 10.1007/s12160-013-9486-6 pubmed: 23512568 pmcid: 23512568
Sørensen K, Van den Broucke S, Fullam J, Doyle G, Pelikan J, Slonska Z. Brand H; (HLS-EU) Consortium Health Literacy Project European. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health. 2012 Jan 25;12(1):80. https://doi.org/10.1186/1471-2458-12-80 .
doi: 10.1186/1471-2458-12-80 pubmed: 22276600 pmcid: 22276600
Albouy-Llaty M, Dupuis A, Grignon C, Strezlec S, Pierre F, Rabouan S, et al. Estimating drinking-water ingestion and dermal contact with water in a French population of pregnant women: the EDDS cohort study. J Expo Sci Environ Epidemiol. 2015 May;25(3):308–16. https://doi.org/10.1038/jes.2014.48 .
doi: 10.1038/jes.2014.48 pubmed: 25073435 pmcid: 25073435
Vallieres EF, Vallerand RJ. The Rosenberg’s self-esteem scale - French-Canadian translation and validation [Traduction et validation canadienne-française de l’échelle de l’estime de soi de Rosenberg]. International Journal of Psychology. 1990;25(2):305–16. https://doi.org/10.1080/00207599008247865 .
Célant N, Guillaume S, Rochereau T. The European Health Survey - Health and Social Protection Survey 2014 [L’Enquête santé européenne - Enquête santé et protection sociale (EHIS-ESPS) 2014]. In: Les rapports de l'IRDES. https://www.irdes.fr/recherche/rapports/566-enquete-sante-europeenne-ehis-enquete-sante-et-protection-sociale-esps-2014.pdf (2014) Accessed 6 May 2020.
Enquête Nationale Périnatale (ENP): Births in 2010 and their evolution since 2003 [Les naissances en 2010 et leur évolution depuis 2003). http://solidarites-sante.gouv.fr/IMG/pdf/Les_naissances_en_2010_et_leur_evolution_depuis_2003.pdf (2011). Accessed 6 May 2020.
Heaman MI, Gupton AL. Psychometric testing of the Perception of Pregnancy Risk Questionnaire. Res Nurs Health. oct. 2009;32(5):493–503. https://doi.org/10.1002/nur.20342 .
Che S-R, Barrett ES, Velez M, Conn K, Heinert S, Qiu X. Using the health belief model to illustrate factors that influence risk assessment during pregnancy and implications for prenatal education about endocrine disruptors. Policy Futur Educ. 1 oct 2014;12(7):961-974.
Grignon C, Venisse N, Rouillon S, Brunet B, Bacle A, Thevenot S, et al. Ultrasensitive determination of bisphenol A and its chlorinated derivatives in urine using a high-throughput UPLC-MS/MS method. Anal Bioanal Chem. 2016;408(9):2255–63. https://doi.org/10.1007/s00216-015-9288-8 .
doi: 10.1007/s00216-015-9288-8 pubmed: 26753970 pmcid: 26753970
Migeot V, Dupuis A, Cariot A, Albouy-Llaty M, Pierre F, Rabouan S. Bisphenol A and its chlorinated derivatives in human colostrum. Environ Sci Technol. 2013;47(23):13791–7. https://doi.org/10.1021/es403071a .
doi: 10.1021/es403071a pubmed: 24229370 pmcid: 24229370
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH Harmonised Tripartite Guideline - Validation of Analytical Procedures: Text and Methodology Q2(R1). https://database.ich.org/sites/default/files/Q2_R1__Guideline.pdf (2005). Accessed 6 May 2020.
NORMAN Network: Protocol for the validation of chemical and biological monitoring methods. https://www.norman-network.net/sites/default/files/files/QA-QC%20Issues/norman_v1_v2_v3_version_02_final_feb2009.pdf (2009).
European Medicines Agency, Committee for Medicinal Products for Human Use: Guideline on Bioanalytical Method Validation. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf (2015). Accessed 6 May 2020.
U.S. Department of Health and Human Services. Food and Drug Administration (FDA). Center for Drug Evaluation and Research (CDER). Center for Veterinary Medicine (CVM). Guidance for industry on bioanalytical method validation. http://www.ag-lab.org/sites/default/files/pdf/media/1/Bioanalytical%20method%20validation.pdf (2001) Accessed 6 May 2020.
Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999 Sep;89(9):1322–7. https://doi.org/10.2105/AJPH.89.9.1322 .
doi: 10.2105/AJPH.89.9.1322 pubmed: 10474547 pmcid: 1508772
Ribreau L. Environmental Health Education Workshops in the PREVED Study: Pregnancy, Prevention, Endocrine Disruptors [Ateliers d’éducation pour la santé environnementale dans le cadre de l’étude PREVED: Pregnancy, Prevention, Endocrine Disruptors]. http://nuxeo.edel.univ-poitiers.fr/nuxeo/site/esupversions/61904b1f-97b7-48a9-a234-e74ac21b9b05 (2018).
Charlet NM. Prevention and promotion actions for environmental health - the example of PREVED, analysis of the action “my house, my health environment” [Les actions de prévention et de promotion en santé environnementale - L’exemple de PREVED, analyse de l’action “ma maison, mon environnement santé”]. [Master’s degree in Public Health]. Le Kremlin Bicêtre, France: Université Paris Sud; 2017.
Ottawa Statement from the Sparking Solutions Summit on Population Health Intervention Research: Ottawa, Ontario, Canada April 25, 2016. Can J Public Health. 2016 Nov;107(6):e492–6.
Jackson SF. Global health promotion and population health intervention research. Glob Health Promot. 2017 Sep;24(3):3–4. https://doi.org/10.1177/1757975917723779 .
doi: 10.1177/1757975917723779 pubmed: 29271307 pmcid: 29271307
Moore G, Cambon L, Michie S, Arwidson P, Ninot G, Ferron C, et al. Discussion Panel. Population health intervention research: the place of theories. Trials. 2019 Jun 11;20(1):285. https://doi.org/10.1186/s13063-019-3383-7 .
doi: 10.1186/s13063-019-3383-7 pubmed: 31186053 pmcid: 31186053
Cambon L, Alla F. Current challenges in population health intervention research. J Epidemiol Community Health. 2019 Nov;73(11):990–2. https://doi.org/10.1136/jech-2019-212225 Epub 2019 Jul 17.
Rudel RA, Gray JM, Engel CL, Rawsthorne TW, Dodson RE, Ackerman JM, et al. Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ Health Perspect. 2011 Jul;119(7):914–20. https://doi.org/10.1289/ehp.1003170 .
doi: 10.1289/ehp.1003170 pubmed: 21450549 pmcid: 21450549
Harley KG, Kogut K, Madrigal DS, Cardenas M, Vera IA, Meza-Alfaro G, et al. Reducing phthalate, paraben, and phenol exposure from personal care products in adolescent girls: findings from the HERMOSA intervention study. Environ Health Perspect. 2016 Oct;124(10):1600–7. https://doi.org/10.1289/ehp.1510514 .
doi: 10.1289/ehp.1510514 pubmed: 26947464 pmcid: 26947464
Hagobian T, Smouse A, Streeter M, Wurst C, Schaffner A, Phelan S. Randomized intervention trial to decrease bisphenol A urine concentrations in women: pilot study. J Womens Health (Larchmt). 2017 Feb;26(2):128–32. https://doi.org/10.1089/jwh.2016.5746 .
doi: 10.1089/jwh.2016.5746
Sathyanarayana S, Alcedo G, Saelens BE, Zhou C, Dills RL, Yu J, et al. Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures. J Expo Sci Environ Epidemiol. 2013 Jul;23(4):378–84. https://doi.org/10.1038/jes.2013.9 .
doi: 10.1038/jes.2013.9 pubmed: 23443238 pmcid: 23443238
Fisher M, Arbuckle TE, Mallick R, LeBlanc A, Hauser R, Feeley M, et al. Bisphenol A and phthalate metabolite urinary concentrations: daily and across pregnancy variability. J Expo Sci Environ Epidemiol. 2015;25(3):231–9. https://doi.org/10.1038/jes.2014.65 .
doi: 10.1038/jes.2014.65 pubmed: 25248937 pmcid: 25248937
Jusko TA, Shaw PA, Snijder CA, Pierik FH, Koch HM, Hauser R, et al. Reproducibility of urinary bisphenol A concentrations measured during pregnancy in the Generation R Study. J Expo Sci Environ Epidemiol. 2014;24(5):532–6. https://doi.org/10.1038/jes.2014.23 .
doi: 10.1038/jes.2014.23 pubmed: 24736100 pmcid: 24736100
Smith KW, Braun JM, Williams PL, Ehrlich S, Correia KF, Calafat AM, et al. Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy. Environ Health Perspect. 2012;120(11):1538–43. https://doi.org/10.1289/ehp.1104614 .
doi: 10.1289/ehp.1104614 pubmed: 22721761 pmcid: 22721761
Braun JM, Smith KW, Williams PL, Calafat AM, Berry K, Ehrlich S, et al. Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect. 2012;120(5):739–45. https://doi.org/10.1289/ehp.1104139 .
doi: 10.1289/ehp.1104139 pubmed: 22262702 pmcid: 22262702
Dewalque L, Pirard C, Vandepaer S, Charlier C. Temporal variability of urinary concentrations of phthalate metabolites, parabens and benzophenone-3 in a Belgian adult population. Environ Res. 2015;142:414–23. https://doi.org/10.1016/j.envres.2015.07.015 .
doi: 10.1016/j.envres.2015.07.015 pubmed: 26233661 pmcid: 26233661
Lassen TH, Frederiksen H, Jensen TK, Petersen JH, Main KM, Skakkebæk NE, et al. Temporal variability in urinary excretion of bisphenol A and seven other phenols in spot, morning, and 24-h urine samples. Environmental Research. 2013;126:164–70. https://doi.org/10.1016/j.envres.2013.07.001 .
doi: 10.1016/j.envres.2013.07.001 pubmed: 23932849 pmcid: 23932849
Nohr EA, Liew Z. How to investigate and adjust for selection bias in cohort studies. Acta Obstet Gynecol Scand. 2018 Apr;97(4):407–16. https://doi.org/10.1111/aogs.13319 .
doi: 10.1111/aogs.13319 pubmed: 29415329 pmcid: 29415329
Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol. 2009 Nov;23(6):597–608. https://doi.org/10.1111/j.1365-3016.2009.01062.x .
doi: 10.1111/j.1365-3016.2009.01062.x pubmed: 19840297 pmcid: 19840297
Beck E, Lechner A, Schaefer C. Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy. Reprod Toxicol. 2017 Jan;67:79–84. https://doi.org/10.1016/j.reprotox.2016.11.019 .
doi: 10.1016/j.reprotox.2016.11.019 pubmed: 27915015 pmcid: 27915015
Vogel JM. Perils of paradigm: Complexity, policy design, and the Endocrine Disruptor Screening Program. Environ Health. 2005;4(1):2. https://doi.org/10.1186/1476-069X-4-2 .
doi: 10.1186/1476-069X-4-2 pubmed: 15701170 pmcid: 15701170
French Republic. Constitutional law n° 2005-205 of March 1, 2020 in the Charter for the Environment [Loi constitutionnelle n° 2005-205 du 1er mars 2005 relative à la Charte de l’environnement]. https://www.legifrance.gouv.fr/loda/id/JORFTEXT000000790249/ (2005) Accessed 6 May 2020.
Cambon L, Terral P, Alla F. From intervention to interventional system: towards greater theorization in population health intervention research. BMC Public Health. 2019;19(1):339. https://doi.org/10.1186/s12889-019-6663-y .
doi: 10.1186/s12889-019-6663-y pubmed: 30909891 pmcid: 30909891

Auteurs

Houria El Ouazzani (HE)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France. houria.el.fellah.el.ouazzani@univ-poitiers.fr.
Faculty of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, 86000, Poitiers, France. houria.el.fellah.el.ouazzani@univ-poitiers.fr.
BioSPharm Pole, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France. houria.el.fellah.el.ouazzani@univ-poitiers.fr.

Steeve Rouillon (S)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Faculty of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, 86000, Poitiers, France.
BioSPharm Pole, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
UMR CNRS 7285, IC2MP, Poitiers, France.

Nicolas Venisse (N)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
BioSPharm Pole, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.

Lynda Sifer-Rivière (L)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Research Center of Medicine, Sciences, Health and Society (Cermes 3), EHESS, University of Paris Descartes, Villejuif, France.

Antoine Dupuis (A)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Faculty of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, 86000, Poitiers, France.
BioSPharm Pole, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.

Guillaume Cambien (G)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Faculty of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, 86000, Poitiers, France.

Sarah Ayraud-Thevenot (S)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Faculty of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, 86000, Poitiers, France.

Anne-Sophie Gourgues (AS)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.

Pascale Pierre-Eugène (P)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.

Fabrice Pierre (F)

BioSPharm Pole, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Department of Obstetrics and Gynecology and Reproductive Medicine, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.

Sylvie Rabouan (S)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Faculty of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, 86000, Poitiers, France.

Virginie Migeot (V)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Faculty of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, 86000, Poitiers, France.
BioSPharm Pole, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.

Marion Albouy-Llaty (M)

Health-Endocrine Disruptors-EXposome (HEDEX), INSERM-CIC1402, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.
Faculty of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, 86000, Poitiers, France.
BioSPharm Pole, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers CEDEX, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH